Brazil’s Anvisa rejects bid to import Bharat Biotech vaccine
Sao Paulo: Brazilian health regulator Anvisa rejected a request from the government to import doses of Covaxin, the COVID-19 vaccine developed by Indian laboratory Bharat Biotech, citing a lack of safety data and documentation. “The importer did not present all the documents required by law,” said